FDA Approval: Economics, Not Science? Unpacking the System BPC 157: Experimental Peptide Creates Risk for Athletes The FDA scheduled a hearing on peptides and the implications could be significant for prescribers and The Peptide Craze Part 2: BPC 157, NAD and the Truth Behind the Longevity Molecule Hype Injectable Peptides: Out of the Back Alley and Into the Light? Berkley Lifesciences FDA takes first step in possible reversal of ban on some peptides The Washington Post